Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Griesinger

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Cytometry. Part B, Clinical Cytometry|December 30, 2004
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringClaudia Langebrake, Iris Brinkmann, Andrea Teigler-Schlegel, et al.
BMC Cancer|May 10, 2007
Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocolMichael Kreuter, Johan Vansteenkiste, Frank Griesinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group, Claudia Langebrake, Ursula Creutzig, et al.
Oncology Research and Treatment|April 13, 2023
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective StudyRike Geiken-Weinstock, Anna K L Reyners, Frank Griesinger, et al.
Blood|September 17, 2002
Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemiaJorg Basecke, Lukas Cepek, Christine Mannhalter, et al.
Onkologie|October 29, 2013
[Tumor Conference I]Tobias Overbeck, Christoph Schäper, Frank Griesinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 27, 2022
Lung Cancer in GermanyNikolaj Frost, Frank Griesinger, Hans Hoffmann, et al.
BMC Health Services Research|June 28, 2022
Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer caseSina Neugebauer, Frank Griesinger, Sabine Dippel, et al.
Translational Lung Cancer Research|March 4, 2022
<i>TP53</i> co-mutations as an independent prognostic factor in 2nd and further line therapy-<i>EGFR</i> mutated non-small cell lung cancer IV patients treated with osimertinibJulia Roeper, Petros Christopoulos, Markus Falk, et al.
Journal of Gastrointestinal Cancer|May 29, 2025
Adherence to Multidisciplinary Tumor Board Recommendations and Its Association with Survival: A Retrospective Observational Study of Colorectal Cancer PatientsEsin Aysel Kandemir, Julia Roeper, Heiner Zimmermann, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Cytometry. Part B, Clinical Cytometry|December 30, 2004
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringClaudia Langebrake, Iris Brinkmann, Andrea Teigler-Schlegel, et al.
BMC Cancer|May 10, 2007
Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocolMichael Kreuter, Johan Vansteenkiste, Frank Griesinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group, Claudia Langebrake, Ursula Creutzig, et al.
Oncology Research and Treatment|April 13, 2023
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective StudyRike Geiken-Weinstock, Anna K L Reyners, Frank Griesinger, et al.
Blood|September 17, 2002
Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemiaJorg Basecke, Lukas Cepek, Christine Mannhalter, et al.
Onkologie|October 29, 2013
[Tumor Conference I]Tobias Overbeck, Christoph Schäper, Frank Griesinger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 27, 2022
Lung Cancer in GermanyNikolaj Frost, Frank Griesinger, Hans Hoffmann, et al.
BMC Health Services Research|June 28, 2022
Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer caseSina Neugebauer, Frank Griesinger, Sabine Dippel, et al.
Translational Lung Cancer Research|March 4, 2022
<i>TP53</i> co-mutations as an independent prognostic factor in 2nd and further line therapy-<i>EGFR</i> mutated non-small cell lung cancer IV patients treated with osimertinibJulia Roeper, Petros Christopoulos, Markus Falk, et al.
Journal of Gastrointestinal Cancer|May 29, 2025
Adherence to Multidisciplinary Tumor Board Recommendations and Its Association with Survival: A Retrospective Observational Study of Colorectal Cancer PatientsEsin Aysel Kandemir, Julia Roeper, Heiner Zimmermann, et al.
Pageof 16